The research results of teachers from the Smart Medical Research Institute in the Science sub-journal reveal the modern scientific explanation of the principle of "syndrome differentiation and treatment" of traditional Chinese medicine

Recently, Dr. Gan Xiao, a member of the team of Professor Xu Jun of the Smart Medical Research Institute of the School of Artificial Intelligence of Nanjing University of Information Science & Technology, Professor Zhou Xuezhong of Beijing Jiaotong University, the founder of network science, an academician of the European Academy of Arts and Sciences, and Professor Albert-László Barabási of Northeastern University, as well as a joint team including the China Academy of Chinese Medical Sciences and the Hubei Provincial Hospital of Traditional Chinese Medicine published a research paper “Network medicine framework reveals” in Science Advances (a top journal of the Chinese Academy of Sciences, impact factor IF=13.6). “generic herb-symptom effectiveness of Traditional Chinese Medicine (network medicine theory reveals the universal rules of clinical efficacy of traditional Chinese medicine)”, Dr. Gan Xiao of our hospital is the first author and co-corresponding author. This paper found that the traditional treatment principle of “syndrome differentiation and treatment” of traditional Chinese medicine can be explained by the topological proximity relationship between traditional Chinese medicine and disease symptoms on the protein network, and was verified by real-world clinical data. It was the first time to explore and establish a scientific theory to explain the principle of traditional Chinese medicine treatment system.

The research results of teachers from the Smart Medical Research Institute in the Science sub-journal reveal the modern scientific explanation of the principle of “syndrome differentiation and treatment” of traditional Chinese medicine

Paper link: https://www.science.org/doi/10.1126/sciadv.adh0215

Research background

Traditional Chinese medicine is a traditional medical system with unique advantages and characteristics in my country. It has significant clinical efficacy. Scientific explanation of the treatment laws of traditional Chinese medicine is an urgent need for the modernization of traditional Chinese medicine and a priority development area of the country’s “14th Five-Year Plan”. Syndrome differentiation and treatment, as the main clinical diagnosis and treatment method of traditional Chinese medicine, is an individualized diagnosis and treatment system with traditional Chinese medicine characteristics based on the four diagnostic methods of traditional Chinese medicine and symptoms and signs, involving complex system laws such as drugs, diseases, and the human body. Therefore, “explaining and clarifying the clinical efficacy of traditional Chinese medicine” is still an unsolved problem. As an important part of syndrome differentiation and treatment, the mechanism of clinical efficacy of traditional Chinese medicine-symptoms (drug-disease relationship) that carries the universal law of addition and subtraction according to the disease needs to be elucidated, which is a key scientific issue related to the clinical efficacy of traditional Chinese medicine and pharmacological research of traditional Chinese medicine. In recent years, with the help of the increasingly complete human protein interaction network, emerging Western medicine network medicine theories and methods have revealed that Western medicine targets and disease-associated proteins have universal topological proximity relationships on the human protein network.

The research results of teachers from the Smart Medical Research Institute in the Science sub-journal reveal the modern scientific explanation of the principle of “syndrome differentiation and treatment” of traditional Chinese medicine

Research results

In this paper, Dr. Gan Xiao proposed the network medicine theory and method of traditional Chinese medicine. He believed that the “prescribing the right medicine” in clinical syndrome differentiation and treatment of traditional Chinese medicine can be explained by the topological proximity relationship between traditional Chinese medicine targets and symptom-related protein modules on the complete human protein network. The paper first proposed and verified the modularity of symptom-related genes on the human protein network. The closer the network distance of symptom modules is, the easier it is for symptoms to co-occur. Then, the paper points out that there is a universal network proximity relationship between curative Chinese medicines and symptoms, that is, Chinese medicine targets are more likely to be curative when they are close to symptom-associated proteins. It also proposes a variety of network proximity indicators as mathematical models to quantitatively describe this proximity relationship. Subsequently, the paper systematically verified the network proximity law of the clinical efficacy of traditional Chinese medicine-symptoms through effective traditional Chinese medicine-symptoms recorded in the Chinese Pharmacopoeia and real-world hospital clinical patient data. Finally, the paper points out that the network proximity relationship on the human protein network can be used as an indicator for predicting the efficacy of traditional Chinese medicine and drug redirection, and predicts a series of drug-disease combinations that are not recorded in the “Chinese Pharmacopoeia” but are significantly effective in clinical data, as potential Chinese medicine treatment options.

The research results of teachers from the Smart Medical Research Institute in the Science sub-journal reveal the modern scientific explanation of the principle of “syndrome differentiation and treatment” of traditional Chinese medicine

Significance and prospects

This work is an original scientific theory. It is the first time that a modern scientific explanation of the treatment principles of traditional Chinese medicine is proposed from the perspective of complex networks and systems, and its effectiveness is verified based on real-world clinical data. This is also the first time that a systematic scientific theory of traditional Chinese medicine has been published in a top journal at the Science sub-journal level, which is of great significance for promoting the modernization and internationalization of traditional Chinese medicine. This study establishes a new research paradigm on the principles of traditional Chinese medicine and indicates that the complete human protein network may be the next hot topic in pharmacological research on traditional Chinese medicine. Finally, the traditional Chinese medicine network medicine theory proposed in the paper may be transformed into applications such as efficacy prediction and drug redirection of new traditional Chinese medicines/medicinal compounds.

Paper citations

Xiao Gan et al., Network medicine framework reveals generic herb-symptom effectiveness of traditional Chinese medicine. Sci.Adv.9,eadh0215(2023).DOI:10.1126/sciadv.adh0215

Author introduction

The research results of teachers from the Smart Medical Research Institute in the Science sub-journal reveal the modern scientific explanation of the principle of “syndrome differentiation and treatment” of traditional Chinese medicine

Gan Xiao, male, graduated from the Science Intensive Department of Kuang Yaming College of Nanjing University and received his PhD from the Department of Physics of Pennsylvania State University in the United States. After graduating from the Ph.D., he served as a postdoctoral researcher at Northeastern University and Pennsylvania State University, studying under Professor Albert-László Barabási, an academician of the European Academy of Arts and Sciences and the founder of network science. Dr. Gan Xiao’s main research direction is complex networks and their modeling in biomedical systems. As the first author or co-first author, he has published papers in top journals such as Science Advances, PNAS, Phys. Rev. E., etc., with a total of more than 600 citations (Google Scholar).

Google Scholar homepage:

https://scholar.google.com/citations?user=EOFin10AAAAJ&hl=en

Chinese homepage:

https://faculty.nuist.edu.cn/ganxiao/zh_CN/index.htm


Translated from the original Chinese source.

Tags :
Share :

Related Posts

The paper jointly written by Zhou Zhenghao, a graduate student at the Smart Medical Research Institute, and Dr. Xia Yi from CUHK Hospital was accepted by Radiology, the top journal in the field of medical imaging.

The paper jointly written by Zhou Zhenghao, a graduate student at the Smart Medical Research Institute, and Dr. Xia Yi from CUHK Hospital was accepted by Radiology, the top journal in the field of medical imaging.

Research background With the innovation of imaging diagnosis technology, advances in surgical procedures, and the use of targeted and immunological drugs, the overall survival of patients with hepatocellular carcinoma (HCC) has greatly improved, but the 5-year survival is still low. One of the reasons is that patients already have microvascular invasion (MVI) when they are diagnosed. MVI refers to the invasion of microvessels by tumors. Under the microscope, nests of cancer cells are seen in the vascular lumen lined with endothelial cells. They are commonly found in small portal vein branches and hepatic vein branches in the adjacent liver tissue, as shown in Figure 1. The incidence rate of MVI is between 15% and 57.1%. Its occurrence indicates that the biological behavior of HCC is more aggressive. Therefore, it is an important factor affecting the prognosis of liver cancer and an important reference for the formulation of treatment plans. In recent years, a large number of studies have attempted to use CT, MRI and other imaging methods combined with clinical and laboratory indicators to predict MVI preoperatively, which can help guide treatment decisions for patients with liver cancer.

Read More
Academician Ma Yuqiang, Vice Chairman of the Provincial CPPCC and Chairman of the Provincial Committee for Democratic Progress, and his delegation visited the Smart Medical Research Institute for investigation

Academician Ma Yuqiang, Vice Chairman of the Provincial CPPCC and Chairman of the Provincial Committee for Democratic Progress, and his delegation visited the Smart Medical Research Institute for investigation

On the afternoon of April 12, Deputy Chairman of the Provincial Committee of the Chinese People’s Political Consultative Conference Chairman, Chairman of the Provincial Committee for the Advancement of Democracy and Academician of the Chinese Academy of Sciences Ma Yuqiang and his delegation went to Nanjing University of Information Science & Technology-Zhongda Hospital Smart Medical Research Institute for research and guidance. Zhu Yimin, full-time deputy chairman of the Provincial Committee for the Democracy and first-level inspector, and Deputy Chairman of the Provincial Committee for the Democracy Yuan Linwang, Vice President of the Committee and Nanjing Normal University, relevant persons in charge of the Party Affairs Office of the United Front Work Department of the Provincial Party Committee, the Graduate Office of the Provincial Department of Education, members of the Provincial Political Consultative Conference, relevant persons in charge of the Suzhou CPPCC Committee, specially appointed researchers of the Provincial Committee for Democracy and persons in charge of the Research Office participated in the survey. Liu Bo, Vice President of our school, Chen Tao, Member of the Standing Committee of the School Party Committee and Director of the United Front Work Department of the Party Committee, and Lai Peng, Deputy Director of the Discipline Construction Department, accompanied him.

Read More
The Smart Medical Research Institute team visited many hospitals in Shanghai for exchanges

The Smart Medical Research Institute team visited many hospitals in Shanghai for exchanges

Subsequently, the institute team conducted academic exchanges with the team of Director Zhou Zhengrong of the Department of Radiation Diagnosis of Fudan Cancer Hospital. Department of Radiation Diagnosis Dr. Xie Tiansong and Dr. Liu Wei gave academic reports on “Progress in Imaging Diagnosis of Neuroendocrine Tumor Liver Metastasis” and “Progress in Imaging Research of Pancreatic Cancer” respectively. They introduced the current research progress of neuroendocrine tumor liver metastasis and pancreatic cancer to the engineering team of the Smart Medical Research Institute, and raised scientific issues of clinical concern. The two parties had a heated discussion on how to use advanced artificial intelligence technology to solve clinical concerns and formulated plans for further cooperation.

Read More